fluoxetine has been researched along with vortioxetine in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (63.64) | 24.3611 |
| 2020's | 8 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| David, DJ; Ebert, B; Gardier, AM; Guiard, BP; Guilloux, JP; Hen, R; Mendez-David, I; Miller, S; Orvoën, S; Pehrson, A; Repérant, C; Sanchez, C | 1 |
| Bétry, C; Etiévant, A; Haddjeri, N; Pehrson, A; Sánchez, C | 1 |
| Pehrson, AL; Sanchez, C | 1 |
| Abdourahman, A; Gulinello, M; Li, Y; Pehrson, AL; Sánchez, C; Tamm, JA | 1 |
| Chen, F; Sánchez, C; Waller, JA | 1 |
| Chen, F; du Jardin, KG; Nyengaard, JR; Sanchez, C; Waller, JA; Wegener, G | 1 |
| du Jardin, KG; Elfving, B; Müller, HK; Sanchez, C; Wegener, G | 1 |
| du Jardin, KG; Elfving, B; Liebenberg, N; Müller, HK; Sanchez, C; Wegener, G | 1 |
| Abdourahman, A; Cajina, M; Li, Y; Pehrson, AL; Sánchez, C; Tamm, JA; Waller, JA | 1 |
| Gulinello, M; Li, Y; Sanchez, C | 1 |
| Ardalan, M; Chen, F; Danladi, J; Elfving, B; Müller, HK; Nyengaard, JR; Sanchez, C; Wegener, G | 1 |
| Ho, CS; Ho, RC; Lu, Y; McIntyre, RS; Wang, W | 1 |
| Kus, K; Nowakowska, E; Ratajczak, PK; Szczepański, M; Zaprutko, T | 1 |
| Balling, C; Chelminski, I; Dalrymple, K; Zimmerman, M | 1 |
| Chen, C; Shan, W | 1 |
| Hrtanek, I; Kertys, M; Krivosova, M; Mokry, J; Ondrejka, I; Tonhajzerova, I | 1 |
| Chen, D; Chen, Z; Luo, S; Wang, Q; Xie, L | 1 |
| Ardalan, M; Chen, F; Danladi, J; Nyengaard, JR; Sanchez, C; Wegener, G | 1 |
| Badcock, PB; Bailey, AP; Cox, GR; Hetrick, SE; McKenzie, JE; Meader, N; Merry, SN; Moller, CI; Sharma, V | 1 |
| DelBello, MP; Emslie, GJ; Ettrup, A; Findling, RL; Petersen, ML; Rosen, M; Schmidt, SN; Zuddas, A | 1 |
| Andrade, C | 1 |
| Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Okuya, M; Sakuma, K | 1 |
4 review(s) available for fluoxetine and vortioxetine
| Article | Year |
|---|---|
Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants.
Topics: Animals; Antidepressive Agents; Brain; Depressive Disorder, Major; Evidence-Based Medicine; Fluoxetine; GABA Agents; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Neural Inhibition; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin; Sulfides; Synaptic Transmission; Vortioxetine | 2015 |
Pharmacological and non-pharmacological treatments for major depressive disorder in adults: A systematic review and network meta-analysis.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Bupropion; Cognitive Behavioral Therapy; Depressive Disorder, Major; Fluoxetine; Humans; Mirtazapine; Network Meta-Analysis; Treatment Outcome; Venlafaxine Hydrochloride; Vortioxetine | 2019 |
New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Topics: Adolescent; Antidepressive Agents; Bias; Child; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mirtazapine; Network Meta-Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicidal Ideation; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine | 2021 |
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
Topics: Adult; Amitriptyline; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Fluvoxamine; Humans; Mirtazapine; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Reboxetine; Sertraline; Venlafaxine Hydrochloride; Vortioxetine | 2023 |
1 trial(s) available for fluoxetine and vortioxetine
| Article | Year |
|---|---|
Vortioxetine for Major Depressive Disorder in Adolescents: 12-Week Randomized, Placebo-Controlled, Fluoxetine-Referenced, Fixed-Dose Study.
Topics: Adolescent; Adult; Child; Depressive Disorder, Major; Double-Blind Method; Fluoxetine; Humans; Piperazines; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Sulfides; Treatment Outcome; Vortioxetine | 2022 |
17 other study(ies) available for fluoxetine and vortioxetine
| Article | Year |
|---|---|
Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Dentate Gyrus; Diazepam; Drug Evaluation, Preclinical; Exploratory Behavior; Fluoxetine; Immobility Response, Tonic; Male; Mice; Motor Activity; Neurogenesis; Piperazines; Sulfides; Vortioxetine | 2013 |
Effect of the multimodal acting antidepressant vortioxetine on rat hippocampal plasticity and recognition memory.
Topics: Animals; Antidepressive Agents; Cell Proliferation; Cohort Studies; Excitatory Postsynaptic Potentials; Exploratory Behavior; Fluoxetine; Hippocampus; Long-Term Potentiation; Male; Memory, Episodic; Memory, Short-Term; Piperazines; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT3; Recognition, Psychology; RNA-Binding Proteins; Serotonin 5-HT3 Receptor Antagonists; Stress, Psychological; Sulfides; Vortioxetine | 2015 |
Reversal of age-associated cognitive deficits is accompanied by increased plasticity-related gene expression after chronic antidepressant administration in middle-aged mice.
Topics: Aging; Animals; Antidepressive Agents; Cell Proliferation; Cognition Disorders; Female; Fluoxetine; Gene Expression; Hippocampus; Intercellular Signaling Peptides and Proteins; Mice; Mice, Inbred C57BL; Motor Activity; Neural Stem Cells; Neuronal Plasticity; Piperazines; Recognition, Psychology; Serotonin Plasma Membrane Transport Proteins; Sulfides; Swimming; Vortioxetine | 2015 |
Vortioxetine promotes maturation of dendritic spines in vitro: A comparative study in hippocampal cultures.
Topics: Animals; Antidepressive Agents; Cells, Cultured; Dendritic Spines; Duloxetine Hydrochloride; Fluoxetine; Hippocampus; Ketamine; Piperazines; Rats, Sprague-Dawley; Serotonin and Noradrenaline Reuptake Inhibitors; Sulfides; Synapses; Vortioxetine | 2016 |
Vortioxetine promotes early changes in dendritic morphology compared to fluoxetine in rat hippocampus.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Dendrites; Dendritic Spines; Fluoxetine; Hippocampus; Male; Piperazines; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Silver Staining; Sulfides; Time Factors; Vortioxetine | 2016 |
A single dose of vortioxetine, but not ketamine or fluoxetine, increases plasticity-related gene expression in the rat frontal cortex.
Topics: Animals; Antidepressive Agents; Dose-Response Relationship, Drug; Fluoxetine; Frontal Lobe; Gene Expression Regulation; Glutamic Acid; Ketamine; Male; Neuronal Plasticity; Piperazines; Rats; Rats, Sprague-Dawley; Serotonin; Sulfides; Time Factors; Vortioxetine | 2016 |
Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Depressive Disorder; Disease Models, Animal; Fluoxetine; Ketamine; Locomotion; Male; Memory Disorders; Piperazines; Rats; Recognition, Psychology; Selective Serotonin Reuptake Inhibitors; Sulfides; Swimming; Vortioxetine | 2016 |
Chronic vortioxetine treatment in rodents modulates gene expression of neurodevelopmental and plasticity markers.
Topics: Amygdala; Animals; Antidepressive Agents; Biomarkers; Fluoxetine; Frontal Lobe; Gene Expression; Hippocampus; Male; Piperazines; Rats, Sprague-Dawley; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Sulfides; Vortioxetine | 2017 |
Distinct Antidepressant-Like and Cognitive Effects of Antidepressants with Different Mechanisms of Action in Middle-Aged Female Mice.
Topics: Aging; Animals; Antidepressive Agents; Cognition; Cohort Studies; Depression; Duloxetine Hydrochloride; Female; Fluoxetine; Memory; Mice, Inbred C57BL; Piperazines; Psychotropic Drugs; Random Allocation; Space Perception; Sulfides; Vilazodone Hydrochloride; Visual Perception; Vortioxetine | 2017 |
A Critical Role of Mitochondria in BDNF-Associated Synaptic Plasticity After One-Week Vortioxetine Treatment.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; CA1 Region, Hippocampal; Dentate Gyrus; Dynamins; Fluoxetine; Gene Expression; Male; Mitochondria; Neuronal Plasticity; Proto-Oncogene Proteins c-fos; rac1 GTP-Binding Protein; Rats, Sprague-Dawley; RNA, Messenger; Synapses; Vortioxetine | 2018 |
Effects of vortioxetine and fluoxetine on the level of Brain Derived Neurotrophic Factors (BDNF) in the hippocampus of chronic unpredictable mild stress-induced depressive rats.
Topics: Anhedonia; Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Depressive Disorder, Major; Disease Models, Animal; Fluoxetine; Hippocampus; Male; Neurons; Random Allocation; Rats, Sprague-Dawley; Stress, Psychological; Vortioxetine | 2018 |
Antidepressant and anxiolytic efficacy of single, chronic and concomitant use of vortioxetine, dapoxetine and fluoxetine in prenatally stressed rats.
Topics: Animals; Antidepressive Agents; Benzylamines; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Exploratory Behavior; Female; Fluoxetine; Immobility Response, Tonic; Locomotion; Male; Naphthalenes; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Statistics, Nonparametric; Stress, Psychological; Swimming; Time Factors; Treatment Outcome; Vortioxetine | 2019 |
Applying the inclusion/exclusion criteria in placebo-controlled studies to a clinical sample: A comparison of medications.
Topics: Adult; Antidepressive Agents; Controlled Clinical Trials as Topic; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Outpatients; Placebos; Vortioxetine | 2020 |
Simultaneous determination of fluoxetine, venlafaxine, vortioxetine and their active metabolites in human plasma by LC-MS/MS using one-step sample preparation procedure.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Child; Chromatography, High Pressure Liquid; Depressive Disorder, Major; Fluoxetine; Humans; Liquid-Liquid Extraction; Middle Aged; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Venlafaxine Hydrochloride; Vortioxetine; Young Adult | 2020 |
Simultaneous quantification of vortioxetine, fluoxetine and their metabolites in rat plasma by UPLC-MS/MS.
Topics: Animals; Chromatography, High Pressure Liquid; Fluoxetine; Linear Models; Male; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Vortioxetine | 2020 |
The rat hippocampal gliovascular system following one week vortioxetine and fluoxetine.
Topics: Animals; Fluoxetine; Hippocampus; Piperazines; Rats; Rats, Sprague-Dawley; Sulfides; Vascular Endothelial Growth Factor A; Vortioxetine | 2021 |
Psychotropic Drugs With Long Half-Lives: Implications for Drug Discontinuation, Occasional Missed Doses, Dosing Interval, and Pregnancy Planning.
Topics: Female; Fluoxetine; Half-Life; Humans; Pregnancy; Psychotropic Drugs; Substance Withdrawal Syndrome; Vortioxetine | 2022 |